Diagnostic and prognostic evaluation of fluorodeoxyglucose positron emission tomography/computed tomography and its correlation with serum cancer antigen-125 (CA125) in a large cohort of ovarian cancer patients.

@article{Evangelista2015DiagnosticAP,
  title={Diagnostic and prognostic evaluation of fluorodeoxyglucose positron emission tomography/computed tomography and its correlation with serum cancer antigen-125 (CA125) in a large cohort of ovarian cancer patients.},
  author={Laura Evangelista and Maurizia Dalla Palma and Michele Gregianin and Margherita Nardin and Anna Roma and Maria Ornella Nicoletto and Giovanni Nardelli and Vittorina Zagonel},
  journal={Journal of the Turkish German Gynecological Association},
  year={2015},
  volume={16 3},
  pages={137-44}
}
OBJECTIVE We evaluated the efficacy of 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in recurrent disease, response to therapy, and long-term follow-up of ovarian cancer (OC) patients in relation to cancer antigen-125 (CA125) levels and the prognostic meaning of this modality in this subset of subjects. MATERIAL AND METHODS Between 2005 and 2015, we retrospectively evaluated 125 patients affected by OC who underwent FDG PET/CT imaging at our… CONTINUE READING